Stay updated on Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.6.6 was added, and Plain Language Summary as well as Revision: v3.6.5 were removed from the page. This reflects an update to the page's revision history and the removal of a lay-friendly overview from the study record.SummaryDifference0.0%

- Check8 days agoChange Detected- The page now shows an explicit NIH grant/contract entry (2018) under Other Study ID Numbers, signaling a funding source for the trial.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a new revision entry v3.6.5 and removed the previous v3.6.4 from the page history. This update records a minor administrative change to the page's version history with no impact on displayed content.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a minor documentation/version bump; no study details or UI changes are indicated.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded a new publication citation detailing the final KEYNOTE-826 analysis (Ann Oncol, 2025). Updated the record version to Revision: v3.6.3, replacing the previous v3.6.2.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page revision label updated from v3.6.0 to v3.6.2, indicating a minor update to the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.